News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ethics Approval Granted For Tissue Therapeutics 's VitroGro Human Clinical Trial



2/7/2008 3:07:21 PM

Brisbane, Feb 7, 2008 (ABN Newswire) - Biomedical company, Tissue Therapies Limited (ASX: TIS) today announced that formal approval has been received from the Trafalgar Ethics Board in Toronto to proceed with the human clinical trial of VitroGro for the treatment of diabetic and venous ulcers scheduled to begin later this month.

Read at ABN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES